TRIM35 Antibody
- 
								中文名稱(chēng):TRIM35兔多克隆抗體
- 
								貨號(hào):CSB-PA235427
- 
								規(guī)格:¥1100
- 
								圖片:
- 
								其他:
產(chǎn)品詳情
- 
											Uniprot No.:
- 
											基因名:TRIM35
- 
											別名:0710005M05Rik antibody; A430106H13Rik antibody; AW046487 antibody; Hemopoietic lineage switch protein 5 antibody; HLS5 antibody; KIAA1098 antibody; Macrophage derived apoptosis inducing RBCC protein antibody; MAIR antibody; MGC17233 antibody; mKIAA1098 antibody; NC8 antibody; Protein MAIR antibody; Protein Nc8 antibody; TRI35_HUMAN antibody; TRIM35 antibody; Tripartite motif containing 35 antibody; Tripartite motif containing protein 35 antibody; Tripartite motif-containing protein 35 antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human
- 
											免疫原:Fusion protein of Human TRIM35
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標(biāo)記方式:Non-conjugated
- 
											抗體亞型:IgG
- 
											純化方式:Antigen affinity purification
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
- 
											產(chǎn)品提供形式:Liquid
- 
											應(yīng)用范圍:ELISA,WB
- 
											推薦稀釋比:Application Recommended Dilution ELISA 1:2000-1:5000 WB 1:500-1:2000 
- 
											Protocols:
- 
											儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
- 
											功能:E3 ubiquitin-protein ligase that participates in multiple biological processes including cell death, glucose metabolism, and in particular, the innate immune response. Mediates 'Lys-63'-linked polyubiquitination of TRAF3 thereby promoting type I interferon production via DDX58/RIG-I signaling pathway. Can also catalyze 'Lys-48'-linked polyubiquitination and proteasomal degradation of viral proteins such as influenza virus PB2. Acts as a negative feedback regulator of TLR7- and TLR9-triggered signaling. Mechanistically, promotes the 'Lys-48'-linked ubiquitination of IRF7 and induces its degradation via a proteasome-dependent pathway. Reduces FGFR1-dependent tyrosine phosphorylation of PKM, inhibiting PKM-dependent lactate production, glucose metabolism, and cell growth.
- 
											基因功能參考文獻(xiàn):- Authors subsequently investigated whether miR-4417 and TRIM35 regulate HCC cell proliferation and apoptosis through PKM2 Y105 phosphorylation, and the results supported our speculation that miR-4417 targets TRIM35 and regulates the Y105 phosphorylation of PKM2 to promote hepatocarcinogenesis. PMID: 28394882
- Data suggest that pyruvate kinase isoform M2 (PKM2)/tripartite motif-containing 35 (TRIM35) expression could be a biomarker for the prognosis of hepatocellular carcinoma (HCC) and target for cancer therapy. PMID: 25576919
- TRIM35 regulates the Warburg effect and tumorigenicity through interaction with PKM2 in hepatocellular carcinoma. PMID: 25263439
- gene located on chromosome 8p21, a region implicated in leukemias and solid tumors; enforced expression inhibited cell growth, clonogenicity, and tumorigenicity; conceivable HLS5 is one of the tumor suppressor genes thought to reside at the 8p21 locus PMID: 14662771
 
- 
											亞細(xì)胞定位:Cytoplasm. Nucleus.
- 
											蛋白家族:TRIM/RBCC family
- 
											數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
  
 













 
         
           
  
          